Opportunistic infection outcomes in patients receiving corticosteroids for immune checkpoint inhibitor toxicity

被引：0
|
作者：
Cook, Michael [1 ]
Atkins, Michael [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P722
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Low lymphocyte counts and association with clinical outcomes in hospitalized patients with cancer receiving immune checkpoint inhibitor therapy.
    Young, Richard
    Panchal, Hemali
    Ma, Weijie
    Chen, Shuai
    Steele, Aaron Paul
    Iannucci, Andrea A.
    Li, Tianhong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy
    Tsai, Tsung-Han
    Su, Po-Jung
    Huang, Shih-Yu
    Kuo, Ming-Chun
    Lin, Chang-Ting
    Wu, Chia-Che
    Luo, Hao-Lun
    Chen, Chien-Hsu
    Chou, Chih-Chi
    Liu, Ting-Ting
    Huang, Chun-Chieh
    Tsai, Kai-Lung
    Su, Yu-Li
    BMC CANCER, 2023, 23 (01)
  • [43] The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
    Thompson, Nicola A.
    Stewart, Grant D.
    Welsh, Sarah J.
    Doherty, Gary J.
    Robinson, Matthew J.
    Neville, B. Anne
    Vervier, Kevin
    Harris, Simon R.
    Adams, David J.
    Dalchau, Katy
    Bruce, David
    Demiris, Nikolaos
    Lawley, Trevor D.
    Corrie, Pippa G.
    BMC CANCER, 2022, 22 (01)
  • [44] Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
    Jang, Se Ryeong
    Nikita, Nikita
    Banks, Joshua
    Keith, Scott W.
    Johnson, Jennifer M.
    Wilson, Melissa
    Lu-Yao, Grace
    JAMA NETWORK OPEN, 2021, 4 (12)
  • [45] The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
    Nicola A. Thompson
    Grant D. Stewart
    Sarah J. Welsh
    Gary J. Doherty
    Matthew J. Robinson
    B. Anne Neville
    Kevin Vervier
    Simon R. Harris
    David J. Adams
    Katy Dalchau
    David Bruce
    Nikolaos Demiris
    Trevor D. Lawley
    Pippa G. Corrie
    BMC Cancer, 22
  • [46] Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma
    Fletcher, Kylie
    Rehman, Saba
    Irlmeier, Rebecca
    Ye, Fei
    Johnson, Douglas
    ONCOLOGIST, 2024,
  • [47] Impact of Troponin Monitoring on Cardiac Outcomes in Patients Receiving Immune Checkpoint Inhibitors
    Ivanovic, Maja
    Chan, Antonia
    Franquiz, Miguel
    Xu, Sidra
    Lee, Carissa
    Fazal, Muhammad
    You, Jonathan
    Witteles, Ronald
    Neal, Joel
    Wu, Sean
    Waliany, Sarah
    Zhu, Han
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2087 - 2089
  • [48] Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
    Farooqi, Saima Jamil
    Zhao, Zhi
    Oejlert, asa Kristina
    Thunold, Solfrid
    Juul, Hedvig Vidarsdotter
    Bjaanaes, Maria Moksnes
    Horndalsveen, Henrik
    Nymoen, Hanne Marte Gjertsen
    Helland, Aslaug
    Haakensen, Vilde Drageset
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
    Rocha, Marta
    de Sousa, Joao Correia
    Salgado, Marta
    Araujo, Antonio
    Pedroto, Isabel
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2019, 26 (04) : 268 - 274
  • [50] Faecal calprotectin determines non-response to corticosteroids in patients with immune checkpoint inhibitor colitis
    Crothers-Stomps, L.
    Kuo, H.
    Teh, W. X.
    White, L.
    Mohsen, W.
    Ramaswany, P. Kakkadasam
    Mason, R.
    Dzienis, M.
    Patrick, D.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1217 - I1218
12345